Related references
Note: Only part of the references are listed.Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
Marwan G. Fakih et al.
LANCET ONCOLOGY (2022)
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer
Xiulei Mo et al.
CELL (2022)
Physical and functional interactome atlas of human receptor tyrosine kinases
Kari Salokas et al.
EMBO REPORTS (2022)
BRAF-Mutated Advanced Colorectal Cancer: A Rapidly Changing Therapeutic Landscape
Kristen K. Ciombor et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Pan-cancer proteomic map of 949 human cell lines
Emanuel Goncalves et al.
CANCER CELL (2022)
EPH receptor tyrosine kinases phosphorylate the PAR-3 scaffold protein to modulate downstream signaling networks
Sara L. Banerjee et al.
CELL REPORTS (2022)
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
Kristina B. Emdal et al.
CELL REPORTS (2022)
The current state of the art and future trends in RAS-targeted cancer therapies
Salman R. Punekar et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Oncogenic Ras Disrupts Epithelial Integrity by Activating the Transmembrane Serine Protease Hepsin
Topi A. Tervonen et al.
CANCER RESEARCH (2021)
Cancer research needs a better map
Jesse S. Boehm et al.
NATURE (2021)
Anomalous collapses of Nares Strait ice arches leads to enhanced export of Arctic sea ice
G. W. K. Moore et al.
NATURE COMMUNICATIONS (2021)
Mg2+ Transporters in Digestive Cancers
Julie Auwercx et al.
NUTRIENTS (2021)
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Daolin Tang et al.
MOLECULAR CANCER (2021)
Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer
Hayato Mizuta et al.
NATURE COMMUNICATIONS (2021)
Integrated cross-study datasets of genetic dependencies in cancer
Clare Pacini et al.
NATURE COMMUNICATIONS (2021)
A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies
Zhiwei Liu et al.
MOLECULAR CELL (2021)
Comprehensive Clinical and Molecular Characterization of KRASG12C-Mutant Colorectal Cancer
Jason T. Henry et al.
JCO PRECISION ONCOLOGY (2021)
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations
Aditya Bardia et al.
ONCOLOGIST (2020)
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
Ahmed Abbasi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The functional landscape of the human phosphoproteome
David Ochoa et al.
NATURE BIOTECHNOLOGY (2020)
A phase I/II study of PI3Kinase inhibition with copanlisib combined with the anti-PD-1 antibody nivolumab in relapsed/refractory solid tumors with expansions in MSS colorectal cancer.
Christopher Jakubowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Proteome activity landscapes of tumor cell lines determine drug responses
Martin Frejno et al.
NATURE COMMUNICATIONS (2020)
Isobaric Matching between Runs and Novel PSM-Level Normalization in MaxQuant Strongly Improve Reporter Ion-Based Quantification
Sung-Huan Yu et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Y772 phosphorylation of EphA2 is responsible for EphA2-dependent NPC nasopharyngeal carcinoma growth by Shp2/Erk-1/2 signaling pathway
Yi-Ping Xiang et al.
CELL DEATH & DISEASE (2020)
Comprehensive characterization of the phospho-proteome of gastric cancer from endoscopic biopsy specimens
Yuichi Abe et al.
THERANOSTICS (2020)
EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer
Giulia Martini et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Suhas Vasaikar et al.
CELL (2019)
Identification of modules and functional analysis in CRC subtypes by integrated bioinformatics analysis
Ru Chen et al.
PLOS ONE (2019)
A Curated Resource for Phosphosite- specific Signature Analysis
Karsten Krug et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
UniProt: a worldwide hub of protein knowledge
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2019)
CORUM: the comprehensive resource of mammalian protein complexes2019
Madalina Giurgiu et al.
NUCLEIC ACIDS RESEARCH (2019)
NCCN Guidelines® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Therapeutic strategies to target RAS-mutant cancers
Meagan B. Ryan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Phosphorylation of tight junction transmembrane proteins: Many sites, much to do
Christina M. Van Itallie et al.
TISSUE BARRIERS (2018)
Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters
Yuichi Abe et al.
JOURNAL OF PROTEOME RESEARCH (2017)
jPOSTrepo: an international standard data repository for proteomes
Shujiro Okuda et al.
NUCLEIC ACIDS RESEARCH (2017)
Detection of dysregulated protein-association networks by high-throughput proteomics predicts cancer vulnerabilities
John D. Lapek et al.
NATURE BIOTECHNOLOGY (2017)
WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit
Jing Wang et al.
NUCLEIC ACIDS RESEARCH (2017)
Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells
Theodoros I. Roumeliotis et al.
CELL REPORTS (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
Philip D. Dunne et al.
CLINICAL CANCER RESEARCH (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Phosphoproteomic analysis of interacting tumor and endothelial cells identifies regulatory mechanisms of transendothelial migration
Marie Locard-Paulet et al.
SCIENCE SIGNALING (2016)
Phosphoproteomic analysis of interacting tumor and endothelial cells identifies regulatory mechanisms of transendothelial migration
Marie Locard-Paulet et al.
SCIENCE SIGNALING (2016)
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
Filippo Pietrantonio et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
dSysMap: exploring the edgetic role of disease mutations
Roberto Mosca et al.
NATURE METHODS (2015)
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
Enzo Medico et al.
NATURE COMMUNICATIONS (2015)
Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
Brinton Seashore-Ludlow et al.
CANCER DISCOVERY (2015)
Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
Markus Morkel et al.
ONCOTARGET (2015)
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Peter V. Hornbeck et al.
NUCLEIC ACIDS RESEARCH (2015)
cocor: A Comprehensive Solution for the Statistical Comparison of Correlations
Birk Diedenhofen et al.
PLOS ONE (2015)
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC
Katherine R. Arnato et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Fibulin-2 Is a Driver of Malignant Progression in Lung Adenocarcinoma
Brandi N. Baird et al.
PLOS ONE (2013)
K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc
Kirti Magudia et al.
JOURNAL OF CELL BIOLOGY (2012)
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2011)
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
Hui Miao et al.
CANCER CELL (2009)
Weak functional constraints on phosphoproteomes
Christian R. Landry et al.
TRENDS IN GENETICS (2009)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma
Jyotsnabaran Halder et al.
CANCER RESEARCH (2007)
Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling
Yiguo Wang et al.
EMBO JOURNAL (2006)
Par-3 controls tight junction assembly through the Rac exchange factor Tiam1
XY Chen et al.
NATURE CELL BIOLOGY (2005)
Share Paper
